Use Of A Tongue Strength Training Device And Its Relationship With Speech In Patients With Parkinson's Disease

Launched by HOSPITAL DE CLINICAS DE PORTO ALEGRE · Apr 3, 2025

Keywords

ClinConnect Summary

This clinical trial is studying whether a special device called the Iowa Oral Performance Instrument (IOPI) can help improve speech in people with Parkinson's Disease (PD). Parkinson's can cause problems with movement and speaking as the disease progresses, so finding effective ways to help with speech is very important. In this study, participants will be divided into two groups. One group will receive therapy using the IOPI device, while the other group will not. Before and after the therapy, participants will take various speech tests to see if the IOPI therapy makes a difference in their ability to communicate.

To be eligible for this trial, individuals must be at least 18 years old and have been diagnosed with Parkinson's Disease. They should be attending specific outpatient services at a healthcare hospital and must not be taking medication that could interfere with the study. Participants can expect to engage in speech tests and receive therapy aimed at improving their speech skills. This research aims to provide new ways for therapists to help individuals with Parkinson's speak more clearly and confidently.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All individuals with an age greater than or equal to 18 years who have been diagnosed with idiopathic PD attended at the Movement Disorders Outpatient and at the Speech Therapy Outpatient Degenerative Adult of a quaternary health care hospital.
• • Who will participate in the project entitled Validation and applicability of the Test of Mastication and Swallowing Solids (TOMASS) for the Brazilian population with Parkinson's disease approved under No. 2023-0402.
• Exclusion Criteria:
• • Subjects who are not currently off the medication;
• • Those whose serious alterations of language and cognition are unable to perform the proposed tasks;
• • Those with other neurological conditions will be excluded.